Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence

作者：Fabio Conforti, Federico Merlo, Laura Pala, Jacopo Canzian, Benedetta Tinterri, Tommaso De Pas, Marzia Locatelli, James Dickerson, Javier Cortés, Dennis J. Slamon, Richard D. Gelber, Vincenzo Bagnardi · 发表于：Journal of Clinical Oncology · 年份：2025 · DOI：10.1200/jco-25-01148 · 被引用次数：1 · 研究领域：Breast Cancer Treatment Studies、Advanced Breast Cancer Therapies、Cancer Risks and Factors